Meet Sarah, 32 After years of battling cravings and stalled progress, Sarah began GLP-1 treatment through BloomMD
Optavia takes a different approach by focusing on structured meal plans and behavioral support
Type 2 diabetes (Ozempic) Maximum dose: 2.0 mg weekly
The FLOW trial showed a 24% reduction in major kidney events in people with type 2 diabetes and CKD, and the SMART trial showed a 52% reduction in urinary albumin leakage, a key marker of kidney damage
PIONEER 4: Head-to-head vs liraglutide 1.8 mg 1,2 Study design: 52-week, randomized, double-blind, double-dummy, active controlled, and placebo-controlled phase 3a trial designed to assess the safety and efficacy of semaglutide tablets vs subcutaneously injected GLP-1 RA, liraglutide
You could just have a neighborhood potluck